Equity of Cancer and Diabetes Co-Occurrence: A National Study With 44 Million Person-Years of Follow-Up (opens on the publisher’s website)
JCO Global Oncology · 2023
Jason Gurney, James Stanley, Andrea Teng, Bridget Robson, Nina Scott, Dianne Sika-Paotonu, Chunhuan Lao, Ross Lawrenson, Jeremy Krebs, Jonathan Koea
- What it found
- Linking national health records for close to five million people over 44 million person-years, the study found people with diabetes had higher cancer rates than people without it, in every ethnic group, with Māori carrying both the highest age-standardised rate (1,303.6 per 100,000 person-years) and the highest rate ratio (1.37, against 1.23-1.35 for the other groups measured). Uterine, pancreatic, kidney and liver cancers showed the strongest links to diabetes across all groups. It is a descriptive study: it establishes the size of the co-occurring burden by ethnicity, not why the gap exists.
- How it was done
- retrospective national cohort using linked administrative data, close to 5 million people, 44 million person-years, 2008-2018
- Why it matters
- It gives a population-level size and shape to the diabetes-cancer overlap Māori carry disproportionately, which matters for anyone planning screening or comorbidity care.
- What it does not settle
- Descriptive/observational - no causal claim is made or should be drawn. There is a related but distinct 2022 PLOS ONE paper by an overlapping author group with a very similar title ("Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up", DOI 10.1371/journal.pone.0276913) - worth not conflating the two. I read the full text via the PMC open-access copy.
Full textfull text (PMC open-access copy)
Read it free: Equity of Cancer and Diabetes Co-Occurrence: A National Study With 44 Million Person-Years of Follow-Up (opens on another organisation’s website)DOI 10.1200/GO.22.00357
